Skip to main content
OpenTrials
Completed

NCT Number: NCT01228812

Physical Activity Behavior of Rheumatoid Arthritis Patients and Healthy Controls

The purpose of the study is to compare physical activity behaviour of rheumatoid arthritis patients with healthy matched controls.

Completed

Looking for future studies?

Notify Me

Key information

Age range

40 year–80 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Centre Hospitalier Universitaire Vaudois, Département de l'Appareil Locomoteur

Lausanne, Switzerland

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

(RA patients):

  • Rheumatoid arthritis
  • Functional classes I, II and III
  • Age 40 to 80 years
  • Stable disease activity
  • Stable DMARDS last 3 months

Exclusion criteria

(RA patients):

  • Functional classes IV
  • Inflammatory flare

Treatment and study plan

Primary outcomes

  1. Physical activity

    Time frame: Up to 4 weeks

    PAFQ

Secondary outcomes

  1. Functional status

    Time frame: Up to 4 weeks

    HAQ

  2. Pain

    Time frame: Up to 4 weeks

    VAS

  3. Fatigue

    Time frame: Up to 4 weeks

    VAS

  4. Disease activity

    Time frame: Up to 4 weeks

    DAS 28

Sponsors and collaborators

Lead sponsor

University of Lausanne

Other

Registry information

Official study title

An Observational Study of Physical Activity Behavior of Swiss Rheumatoid Arthritis Patients and Healthy Matched Controls

Important dates

Study start
2010
Primary completion
2010
Study completion
2010
First posted
Oct 27, 2010
Registry last updated
May 17, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.